| CTRI Number |
CTRI/2020/10/028756 [Registered on: 29/10/2020] Trial Registered Prospectively |
| Last Modified On: |
31/01/2022 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Dentistry Other (Specify) [Orthodontics] |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Are braces effective for patients with unilateral cleft palate undergoing alveolar bone graft surgery? |
|
Scientific Title of Study
|
Reducing the burden of Orthodontic Care for children with Clefts: Evaluating the effectiveness of Pre-alveolar Bone Graft Orthodontics in unilateral non-syndromic Cleft patients (PABO Study) |
| Trial Acronym |
PABO |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Badri Thiruvenkatachari |
| Designation |
Professor in Orthodontics and Director, Dental Research |
| Affiliation |
Sree Balaji Dental College and Hospital |
| Address |
Sree Balaji Dental College and Hospital, Department of Orthodontics and Dentofacial Orthopaedics, Cleft and Craniofacial division, Second floor.
Chennai TAMIL NADU 600100 India |
| Phone |
00917358483837 |
| Fax |
|
| Email |
badri.t.chari@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Badri Thiruvenkatachari |
| Designation |
Professor in Orthodontics and Director, Dental Research |
| Affiliation |
Sree Balaji Dental College and Hospital |
| Address |
Sree Balaji Dental College and Hospital, Department of Orthodontics and Dentofacial Orthopaedics, Cleft and Craniofacial division, Second floor.
Chennai TAMIL NADU 600100 India |
| Phone |
00917358483837 |
| Fax |
|
| Email |
badri.t.chari@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Badri Thiruvenkatachari |
| Designation |
Professor in Orthodontics and Director, Dental Research |
| Affiliation |
Sree Balaji Dental College and Hospital |
| Address |
Sree Balaji Dental College and Hospital, Department of Orthodontics and Dentofacial Orthopaedics, Cleft and Craniofacial division, Second floor.
Chennai TAMIL NADU 600100 India |
| Phone |
8667342684 |
| Fax |
|
| Email |
badri.t.chari@gmail.com |
|
|
Source of Monetary or Material Support
|
| Sant Parmanand Hospital, Delhi |
| SERB - Core research Grant |
| Sree Balaji Dental College & Hospital, Bharath Institute of Higher Education and Research (BIHER) |
| Sri Ramachandra Dental College
Sri Ramachandra Institute of Higher Education and Research |
|
|
Primary Sponsor
|
| Name |
Badri Thiruvenkatachari |
| Address |
Director, Dental Research
Sree Balaji Dental College and Hospital
Bharath Institute of Higher Education and Research
Chennai, Tamil Nadu
India.
|
| Type of Sponsor |
Other [Individual] |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Bharath Institue of Higher Education and Research |
Velachery Main Rd, VGP Rajesh Nagar, Pallikaranai, Chennai,
Tamil Nadu 600100.
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 3 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Puneet Batra |
Sant Parmanand Hospital, Delhi |
Dental Wing, Cleft and Craniofacial division
18, Sham Nath Marg, Civil Lines, New Delhi, Delhi 110054 New Delhi DELHI |
9810335961
drpuneetbatra@gmail.com |
| Dr Badri Thiruvenkatachari |
Sree Balaji Dental College & Hospital, Bharath Institute of Higher Education and Research (BIHER |
Department of Orthodontics and Dentofacial Orthopaedics, Cleft and Craniofacial division, Second floor.
Velachery Main Rd, VGP Rajesh Nagar, Pallikaranai, Chennai,
Tamil Nadu 600100.
Chennai TAMIL NADU |
00917358483837
badri.t.chari@gmail.com |
| Dr Altaf Hussain |
Sri Ramachandra Dental College ,Sri Ramachandra Institute of Higher Education and Research |
Department of Plastic and Reconstructive Surgery,
Cleft and Craniofacial Division,
No.1, Ramachandra Nagar, Porur, Chennai,
Tamil Nadu 600116.
Chennai TAMIL NADU |
9600063199
syedaltafhussain@sriramachandra.edu.in |
|
Details of Ethics Committee
Modification(s)
|
| No of Ethics Committees= 3 |
| Name of Committee |
Approval Status |
| Institutional Ethics Comitee, Sree Balaji Dental College and hospital (BIHER) |
Approved |
| Institutional Ethics Comitee, Sri Ramachandra Institute of Higher Education and Research |
Submittted/Under Review |
| Institutional Ethics Comitee,Institute of Dental Studies and Technologies Delhi, India |
Submittted/Under Review |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: Q351||Cleft hard palate, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
no intervention/no orthodontic treatment |
No orthodontic treatment and pre-graft orthodontics for a period of 2 years |
| Intervention |
Orthodontic treatment |
Orthodontic treatment with pre-alveolar bone graft for a period of two years |
|
|
Inclusion Criteria
|
| Age From |
8.00 Year(s) |
| Age To |
13.00 Year(s) |
| Gender |
Both |
| Details |
Unilateral cleft alveolus requiring alveolar bone graft.
Upper central incisors erupted.
Written informed consent.
One care/parent must be a native language speaker of the state of residence.
|
|
| ExclusionCriteria |
| Details |
Bilateral Cleft palate
Patients with syndromes or other medical condition
Subjects involved in any other orthodontic trials
Inadequate oral hygiene
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Centralized |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
Success of alveolar bone graft assessed from
oblique occlusal (Kindelan method) and
CBCT |
Oblique occlusal: baseline (T1), Pregraft (T3), 3 months post surgery (T4)and six months post surgery (T5)
CBCT: six months post surgery (t%) |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Quality of the dento-occlusal outcome measured on study models using 10 year old index scores |
Six months post surgery (T5) |
| Qualitative assessment using the validated quality of life questionnaires |
All time points T1-T6 |
Quality adjusted cost analysis
|
All time points T1-T6 |
|
Target Sample Size
Modification(s)
|
Total Sample Size="70" Sample Size from India="70"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/11/2020 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
nil |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
The study is a parallel group prospective randomized controlled trial to compare the effectiveness of pre graft orthodontic treatment against no orthodontic treatment controls, a single blinded multi- centered study on 36 cleft patients divided randomly (computer generated) with three centres in India. The primary outcome would be the effectiveness of pre bone alveolar bone graft orthodontic treatment for Children with cleft palate, by the success of alveolar bone graft assessed from CBCT and Lateral oblique (Kindelan method). The secondary outcomes are Quality of the Dento-occlusal outcome measured on study models, Qualitative assessment using the validated quality of life questionnaires Breakages and cost efficiency a longitudinal study. Data analysis will be carried out at the end of the trial and will be on an intention-to-treat basis. The continuous outcomes will be analysed using mean and 95% CI and dichotomous data will be analysed using Chi-squared test and effect estimates reported using relative risks and 95% confidence intervals. |